HOME >> BIOLOGY >> NEWS
Antioxidants decrease disease in a Drosophila model of Alzheimer's disease

Alzheimers disease (AD) is one of a number of neurodegenerative disorders in which brain cells damaged by naturally occurring chemicals known as reactive oxygen species (ROS) have been observed. However, whether this oxidative damage causes neurodegeneration or is a consequence of it has not been previously determined. A study appearing online on December 14, in advance of publication in the January print issue of the Journal of Clinical Investigation, indicates that oxidative damage is a factor contributing to neurodegeneration in a Drosophila model of neurodegenerative disorders such as AD.

Mel Feany and colleagues from Brigham and Womens Hospital and Harvard Medical School assessed neuron cell death in Drosophila expressing a neurodegenerative diseaseassociated form of the human protein tau. The number of dying neurons was increased if these insects were also genetically modified to have high levels of ROS. By contrast, if the insects were treated with the antioxidant vitamin E they had decreased numbers of dying neurons. This demonstration that oxidative stress contributes to neurodegeneration in this model of AD suggests that targeting antioxidant pathways might provide a new approach for treating individuals with AD and other related neurodegenerative disorders.

TITLE: Oxidative stress mediates tau-induced neurodegeneration in Drosophila.


'"/>

Contact: Karen Honey
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
14-Dec-2006


Page: 1

Related biology news :

1. Antioxidants: New kid on the block for pain relief?
2. Dietary vitamin B6, B12 and folate, may decrease pancreatic cancer risk among lean people
3. Stem cells decrease ischemic injury and restore brain function
4. High levels of vitamin D in the body may decrease the risk of multiple sclerosis
5. U of M study shows treatment of periodontal disease does not decrease risk for preterm birth
6. Bacteria increase risk of lower stomach cancer, decreases risk of upper
7. Salivary melatonin may decrease periodontal disease severity according to new study findings
8. Smoking increases risk and omega-3 fatty acids decreases risk of blinding disease
9. Antioxidant tempol prevents pre-eclampsia, decreases fetal mortality in mice
10. Childhood deaths from poisonings have decreased sharply since Mr. Yuk was created 35 years ago
11. Prenatal pesticide exposure and high blood pressure and a decreased ability to copy shapes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2020)... ... June 24, 2020 , ... eClinical ... clinical data services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: ... in hospitalized patients with severe COVID-19. This is the first study of an ...
(Date:6/23/2020)... ... 2020 , ... The field of quantitation of large molecules or proteins has ... area. However, the use of mass spectrometry in this field has gained a lot ... do you choose which approach to use (LBA or MS)?” In many cases, ...
(Date:6/19/2020)... (PRWEB) , ... June 16, 2020 , ... The director ... is betting that if the stem cell medicine and pharmaceutical industries have easier access ... practice. So, starting July 5 of this year, Independence Day weekend in the ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... , ... August 13, 2020 , ... True Terpenes ... creation of its Scientific Advisory Board (SAB) to research the medical potential of terpenes ... be enhanced when combined with terpenes. The board is focused on expanding the recently ...
(Date:8/12/2020)... BINGHAM FARMS, Mich. (PRWEB) , ... August 12, ... ... International Consulting Group, Inc. (EMMA International), a global leader in FDA compliance ... ranking of the nation’s fastest-growing private companies. The list represents a unique look ...
(Date:7/31/2020)... Ariz. (PRWEB) , ... July 29, 2020 , ... R3 ... joint injections for only $3950. With 50 million stem cells total, patients may choose ... stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... have entered into a strategic partnership whereby Catalent will provide support for the ...
Breaking Biology Technology:
Cached News: